Compare RGNX & VKQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RGNX | VKQ |
|---|---|---|
| Founded | 2008 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 528.6M | 535.6M |
| IPO Year | 2015 | 1994 |
| Metric | RGNX | VKQ |
|---|---|---|
| Price | $11.90 | $10.06 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $28.75 | N/A |
| AVG Volume (30 Days) | ★ 2.1M | 200.7K |
| Earning Date | 05-05-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 18.08 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $10,393,000.00 | N/A |
| Revenue This Year | $51.21 | N/A |
| Revenue Next Year | $19.08 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 126.48 | N/A |
| 52 Week Low | $5.46 | $8.94 |
| 52 Week High | $16.19 | $10.06 |
| Indicator | RGNX | VKQ |
|---|---|---|
| Relative Strength Index (RSI) | 79.66 | 69.75 |
| Support Level | $10.75 | $9.54 |
| Resistance Level | $12.05 | N/A |
| Average True Range (ATR) | 0.87 | 0.06 |
| MACD | 0.57 | 0.02 |
| Stochastic Oscillator | 96.16 | 85.00 |
Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.
Invesco Municipal Trust is a diversified, closed-end management investment company. The company's investment objective is to provide a high level of current income exempt from federal income tax, consistent with the preservation of capital.